Philips and MD Anderson Collaborate to Facilitate Personalized Oncology Treatments and Clinical Trial Matching Based on Genomic Markers

Amsterdam, the Netherlands, and Houston, US, June 16 (Korea Bizwire) – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and The University of Texas MD Anderson Cancer Center today announced a collaboration to provide oncologists with evidence-based therapy and clinical trial guidance through Philips’ oncology informatics solutions and MD Anderson’s Precision Oncology Decision Support (PODS) [...]